Each filer's latest filing for 786700104 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Balyasny Asset Management L.P.
13G/A
|
9.0% |
11/16/2026
Event 9/30/2026
|
||
| Balyasny Asset Management L.P. | 9.0% | |||
| Bam GP LLC | 9.0% | |||
| Balyasny Asset Management Holdings LP | 9.0% | |||
| Dames GP LLC | 9.0% | |||
| Dmitry Balyasny | 9.0% | |||
| BlackRock, Inc. 13G | 7.8% |
7/30/2026
Event 6/30/2026
|
||
|
Commodore Capital LP
13G
|
7.6% |
10/7/2026
Event 9/30/2026
|
||
| Commodore Capital LP | 7.6% | |||
| Commodore Capital Master LP | 7.6% | |||
| Robert Egen Atkinson | 7.6% | |||
| Michael Kramarz | 7.6% | |||
|
SilverArc Capital Management, LLC
13G
|
6.1% |
11/13/2026
Event 9/30/2026
|
||
| SilverArc Capital Management, LLC | 6.1% | |||
| Devesh Gandhi | 6.1% | |||
| Woodline Partners LP 13G | 5.1% |
11/16/2026
Event 9/30/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (5) | ||||
|
AP11 Ltd
13G/A
|
4.9% |
6/24/2025
Event 6/24/2025
|
||
| AP11 Limited | 4.9% | |||
| Ascletis Pharma Inc. | 4.9% | |||
| Blue Owl Capital Holdings LP 13G/A | 4.3% |
2/14/2025
Event 12/31/2024
|
||
|
KPCB Pandemic & Bio Defense Fund LLC
13G/A
|
0% |
12/18/2025
Event 12/18/2025
|
||
| KPCB Pandemic and Bio Defense Fund, LLC | 0% | |||
| KPCB PBD Associates, LLC | 0% | |||
|
New Enterprise Associates 13, L.P.
13G/A
|
0% |
5/13/2025
Event 3/31/2025
|
||
| New Enterprise Associates 13, L.P. | 0% | |||
| NEA Partners 13, L.P. | 0% | |||
| Nea 13 GP, Ltd | 0% | |||
| Forest Baskett | 0% | |||
| Anthony A. Florence, Jr. | 0% | |||
| Patrick J. Kerins | 0% | |||
| Mohamad H. Makhzoumi | 0% | |||
| Scott D. Sandell | 0% | |||
|
Point72 Asset Management, L.P.
13G/A
|
0% |
8/14/2025
Event 6/30/2025
|
||
| Point72 Asset Management, L.P. | 0% | |||
| Point72 Capital Advisors, Inc. | 0% | |||
| Steven A. Cohen | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 154 | 69.7 M | $689M |
| 2026 Q2 | 123 | 51.0 M | $394M |
| 2026 Q1 | 88 | 13.4 M | $69.8M |
| 2025 Q4 | 86 | 14.4 M | $85.2M |
| 2025 Q3 | 72 | 12.6 M | $86.7M |
| 2025 Q2 | 68 | 11.7 M | $89.0M |
| 2025 Q1 | 71 | 13.8 M | $44.9M |
| 2024 Q4 | 67 | 17.5 M | $78.8M |
| 2024 Q3 | 64 | 19.7 M | $54.4M |
| 2024 Q2 | 83 | 20.9 M | $71.6M |
| 2024 Q1 | 82 | 22.6 M | $123M |
| 2023 Q4 | 52 | 14.4 M | $76.1M |
| 2023 Q3 | 49 | 15.6 M | $130M |